response to KCl and the Ca 2+ channel activator FPL 64176, and this effect was also attenuated by gp91ds-tat. Conclusion: These results suggest that angiotensin II stimulates endo thelial NAD(P)H oxidase-produced H 2 O 2, which may additionally act through vascular smooth muscle NAD(P)H oxidase, to upregulate vascular Ca V 1.2 protein.
Introduction
Angiotensin II is a potent vasoconstrictor known to activate various signaling pathways en route to causing release of Ca 2+ from intracellular stores and increased activity of L-type Ca V 1.2 calcium channels [1, 2] . Upregulation of Ca V 1.2 in arteries has been reported by us in spontaneously hypertensive rats [3] and also by others in angiotensin II-induced hypertensive animals, where the upregulation of Ca V 1.2 is associated with dysfunction of endothelium [4] . Calcium channel blockers are used as effective antihypertensive therapy in patients, implicating the calcium channel in the pathogenesis of hypertension.
We have recently reported an effect of angiotensin II to increase Ca V 1.2 expression in arteries maintained in organ culture for 24 h in an endothelial-dependent but transcription-independent fashion [5] . The goal of this investigation is to identify some of the principal signaling intermediates in this action of angiotensin II.
Our principal goal was to determine the identity of the substance that the endothelium released which mediated the increase in Ca V 1.2 expression in the vascular smooth muscle cells of the arterial wall. The endothelium is known to release vasoconstrictors such as endothelin [6] and TxA2, as well as vasodilators such as nitric oxide and prostacyclin [7] . Angiotensin II actions have been shown to be mediated by many different signaling pathways [1] . Our observation that its action in cultured arteries was dependent on a functional endothelium [5] caused us to look first at those pathways angiotensin II has been shown to affect in the endothelium. Chief among these is an increase in NAD(P)H oxidase [8] [9] [10] [11] , resulting in an increase in reactive oxygen species (ROS) such as superoxide (O 2 -) and hydrogen peroxide (H 2 O 2 ). These increases can be inhibited by NAD(P)H oxidase inhibitors diphenylene iodonium (DPI) and apocynin [8, [12] [13] [14] [15] and a more specific NAD(P)H peptide inhibitor gp91ds-tat [16] [17] [18] . Endothelial NAD(P)H oxidase-derived ROS play an important role in endothelial dysfunction, which is implicated in cardiovascular diseases such as hypertension, atherosclerosis, and diabetic vascular hypertrophy [13, [19] [20] [21] . It has been reported recently that H 2 O 2 is involved in the regulation of Ca V 1.2 in HL-1 cardiomyocytes [22] . These results led us to investigate whether or not angiotensin II-induced ROS such as H 2 O 2 are also involved in the regulation of Ca V 1.2 expression in vascular smooth muscle cells and furthermore, if they are, what signaling pathways participate in this action.
Methods

Artery Culture
Isolation of mesenteric arteries from freshly euthanized rats was conducted with protocols approved by our institutional animal care and use committee. The superior mesenteric artery of 300-400 g male Sprague Dawley rats was dissected, cleaned of superficial fat, placed in DMEM containing 0.1% fetal bovine serum in 35-mm diameter culture dishes, and maintained in tissue culture at 37 ° C and 5% CO 2 with and without angiotensin II, H 2 O 2 , catalase or NADPH oxidase inhibitors in DMEM with 0.1% fetal bovine serum and antibiotics for 24 h [5] . After this time, arteries were subjected to one (or more) of the following procedures.
Western Blot
Arterial tissue was minced and homogenized on ice in lysis buffer (50 m M NaCl, 25 m M TrisCl, 0.5% Na deoxycholate, 1% IGEPAL CA-630, 1 m M PMSF, 2 g/ml aprotinin, 5 g/ml leupeptin, pH 7.4) and differentially centrifuged at 13,000 g for 10 min to yield a supernatant containing the channels. Protein concentration in the supernatant was determined by a BCA protein assay kit (Pierce) and 20-40 g protein applied to each lane. Western blots were run using 3-8% Tris Acetate gradient gels (Invitrogen) at 150 V for 1 h, and transferred onto PVDF membranes at 32 V for 1.5 h, blocked with NAP blocker (GBiosciences, Geno Technology Inc.) for 2 h and probed for Ca V 1.2 with a primary antibody (1: 1,000) from Alomone versus the II-III linker. Lower molecular weight portions of the blot probed with ␣-actin antibody (Sigma) served as a control for loading. Western blots were quantitated as previously described [3] .
Blood Vessel Tension Recording
Rings (4 mm in length) of the artery were equilibrated in a tissue bath for 1 h prior to measuring tension responses to the L -type Ca 2+ channel agonist FPL 64176. Tension determinations were performed by cutting 4-mm rings of mesenteric vessels and mounting them on force transducers at their optimal length-tension. Rings were equilibrated for 1 h in Krebs-Henseleit solution (m M ): NaCl 118, KCl 5.4, NaH 2 PO 4 1.4, MgSO 4 1.2, NaHCO 3 18, glucose 11 bubbled with 95% O 2 and 5% CO 2 (pH 7.4). During the equilibration period, basal tension was adjusted to 1.5 g. Rings were then exposed to KCl (80 m M ) or Ca 2+ channel activator FPL 64176 [5] .
Endothelial Damage
Endothelial damage was generated by brief intra-arterial perfusion with Krebs-Henseleit solution containing 0.3% CHAPS for approximately 40 s and endothelial damage was confirmed by the lack of vasodilatory response to acetylcholine, as reported in our previous studies [5] . This procedure does not affect vascular smooth muscle vasoconstrictor responses [5, [23] [24] [25] .
levels in the culture solution were determined using the Amplex Red H 2 O 2 assay kit (Molecular Probes, Invitrogen) [26, 27] according to the manufacturer's instructions. Briefly, the superior mesenteric arteries were dissected, cleaned of superficial fat, and cut into pieces (4 mm in length). The pieces were incubated with Amplex Red (50 M ) and horseradish peroxidase (0.1 M ) at 37 ° C for 1 h in 0. 5 [16, 17] and were synthesized by Biosynthesis Inc. This peptide inhibitor is considered to be a more specific NAD(P)H oxidase inhibitor [28, 29] .
Statistical Analysis
Data are presented as mean 8 SEM, and statistical significance was determined by Student's t test between two groups and analysis of variance followed by post hoc test as appropriate between multiple groups. A p value ! 0.05 was considered significant.
Results
Angiotensin II Upregulation of Ca V 1.2 Protein Expression
Angiotensin II (0.05-5 M ) dose-dependently upregulated the expression of Ca V 1.2 protein in cultured mesenteric arteries as shown in figure 1 .
Involvement of NAD(P)H Oxidase in the Upregulation of Ca V 1.2 Protein Expression by Angiotensin II
Our initial attempts to determine signaling pathway intermediates involved in this effect involved screening of inhibitors of different enzymes. We observed that DPI and apocynin, two chemically unrelated inhibitors of the NAD(P)H oxidase enzyme complex [30] [31] [32] [33] , both blocked the angiotensin II-induced upregulation of Ca V 1.2 protein ( fig. 2 ). At the concentration used here, neither DPI nor apocynin alone significantly affected basal Ca V 1.2 protein expression (not shown). Combined with our previous report [5] , which showed that angiotensin II caused an endothelium-dependent upregulation of Ca V 1.2 expression, these results suggested to us that angiotensin II was activating endothelial NAD(P)H oxidase, much as had been reported in vivo by Mollnau et al. [34] and Higashi et al. [12] . We presumed the inhibitory effects of DPI and apocynin were mediated, at least in part, at the level of the endothelium. The involvement of endothelial NAD(P)H oxidase in the upregulation of Ca V 1.2 expression was further confirmed by a more specific NAD(P)H oxidase inhibitor, gp91ds-tat [28, 29] , as shown in figure 3 .
H 2 O 2 Involvement in the Upregulation of Ca V 1.2 Protein Expression
These results suggested that endothelial superoxide generated by NAD(P)H oxidase was involved in the signaling pathway. We next turned to address the identity of the signaling molecule, generated and released by the endothelium of the intima, which signals the vascular smooth muscle of the media to increase expression of Ca V 1.2. Superoxide is highly reactive and not particularly membrane permeable [35] , but it can be converted to H 2 O 2 by superoxide dismutase. H 2 O 2 is a much more stable molecule than superoxide and is cell membrane permeable [21, 32, 35, 36] . In the following experiments we tested the effects of H 2 O 2 . As shown in figure 4 , H 2 O 2 also dose-dependently upregulated expression of Ca V 1.2 in cultured arteries ( fig. 4 ) . Additionally, the angiotensin IIinduced increase in Ca V 1.2 was abrogated by culture in catalase, which converts peroxide to water ( fig. 4 ) [36] . Incubation of endothelial intact arteries in angiotensin II resulted in an increased production of H 2 O 2 , which was inhibited by both NAD(P)H oxidase inhibitors apocynin and catalase ( fig. 5 a) , and also by gp91ds-tat ( fig. 5 b) . After endothelial damage the angiotensin II-induced H 2 O 2 production was greatly reduced ( fig. 5 a) . Finally, arteries with endothelium damaged by brief perfusion with CHAPS prior to culture still responded to H 2 O 2 ( fig. 6 ). These results suggest that peroxide is the likely endothelially derived mediator for the angiotensin II effect on Ca V 1.2 protein expression. Since H 2 O 2 has been reported to stimulate a nonphagocytic NAD(P)H oxidase in vascular smooth muscle cells [37] , the effects of NAD(P)H oxidase inhibition on the increase in Ca V 1.2 expression in arteries by H 2 O 2 was tested. As shown in figure 6 , NAD(P)H oxidase inhibitors DPI and apocynin both inhibited the upregulation of Ca V 1.2 in vascular smooth muscle by H 2 O 2 after endothelial damage.
Upregulation of Ca V 1.2 Function by H 2 O 2
Our previous study reported that upregulation of Ca V 1.2 by angiotensin II is accompanied by an upregulation of functional Ca V 1.2 activity, assessed using the Ca 2+ channel activator FPL 64176 [5] . Similarly, the upregulation of Ca V 1.2 by H 2 O 2 is also accompanied by an increased tension response to both KCl (which depolarizes smooth muscle cells and opens the voltage-dependent Ca V 1.2 channel) and FPL 64176 ( fig. 7 ) . These effects were blocked by the calcium channel blocker nifedipine. fig. 9 ).
Attenuation of Angiotensin II-Induced
Discussion
The present communication describes portions of the signaling pathway involved in the increase in Ca V 1.2 protein in cultured mesenteric artery induced by angiotensin II. Although angiotensin II has also been reported to increase expression of the same channel in HL-1 cardiomyocytes [22] , the effect reported here is significantly different. Endothelial involvement is manifest in this vascular effect but not in the cardiac effect. While both effects involve NAD(P)H oxidase, the cardiac effect involves the cAMP signaling pathway and is transcriptional [20] , whereas the vascular effect examined here is posttranscriptional [5] . The differences in transcriptional regulation should not be surprising, given that the cardiac and vascular forms of the channel are regulated by two separate promoters [38] [39] [40] .
Even though the endothelium is clearly involved in this angiotensin II effect, we can be reasonably certain that the increased Ca V 1.2 expression is not due to increas- es of the protein in the endothelium. Ca V 1.2 is not generally believed to be expressed in endothelium [41] , despite occasional reports to the contrary [42] . Furthermore, expression there would not lead to increased vasoconstriction by a Ca 2+ channel activator such as that observed in our previous studies [5] and in this study. Finally, after endothelial damage, administration of H 2 O 2 still upregulated Ca V 1.2 expression, excluding the possibility that the upregulation of Ca V 1.2 expression is endothelial.
The cultured artery preparation enabled us to determine that the signaling mediator released by endothelium in response to angiotensin II stimulation and causing increases in Ca V 1.2 expression is H 2 O 2 , one of the membrane-permeable ROS [21, 32, 35, 36] . ROS produced by NAD(P)H oxidase in response to angiotensin II stimulation have been described in the endothelium by many authors [8, 19, 20, 43, 44] . H 2 O 2 has been reported to be an endothelial-dependent constricting factor [45] and is known to constrict many different vascular beds at similar concentrations used here [46] [47] [48] , although the contraction is often transient and followed by relaxation [47, 49] . Our H 2 O 2 determination ( fig. 5 ) showed that after endothelial damage angiotensin II had no effect on H 2 O 2 production. We also observed that catalase partially blocked angiotensin II-induced tension increases in mesenteric arteries with intact endothelium, but had no ac- tion in arteries with damaged endothelium (not shown). Therefore, the increase in H 2 O 2 production by angiotensin II is primarily derived from endothelium. Inhibition of angiotensin II-induced vasoconstriction by catalase was also reported by another group [50] . Our results which show that angiotensin II causes an endotheliumdependent increase in ROS production is also supported by other reports [12, 51] . For example, after endothelium denudation, the increased ROS generation induced by angiotensin II in rat aorta was absent [12] , and ROS produced by endothelial NAD(P)H oxidase is a major source of oxygen radical generation in the arterial wall [51] .
Although our standard treatment times were 24 h in culture, generation of H 2 O 2 induced by angiotensin II may start much more rapidly, as shown by our H 2 O 2 measurement results ( fig. 5 ) . We have observed rapid contraction of artery rings in response to angiotensin II, another effect partially inhibited by catalase (not shown), but also observed by others [50] . On the other hand, the effects of H 2 O 2 may last longer, since it was reported that only a 5-min exposure of ventricular myocytes to 30 M H 2 O 2 increased Ca V 1.2-mediated current which persisted for at least 9 h [52] . We also observed that the concentration of H 2 O 2 in culture medium was not stable and degraded very quickly, for example, 250 M H 2 O 2 was degraded to approximately 5 M after 30 min as measured by H 2 O 2 test strips from Thermo Electron Corporation (not shown). Thus, even a short exposure to H 2 O 2 may initiate much later and longer lasting events like the upregulation of Ca V 1.2 protein expression. Considerably more time is likely required for effects on Ca V 1.2 protein levels to be manifest.
A typical mesenteric artery preparation in our experiment has a wet weight of approximately 20 mg (roughly equal to 20 l), from which approximately 0.5 mg protein was extracted. Each artery was cultured in a volume of we used was higher than that in the in vivo condition, in figure 1 we found that even in the nanomolar range (0.05 M ) angiotensin II still upregulated Ca V 1.2 expression. In order to test the mechanism more easily, we chose the middle concentration (0.5 M ) in following experiments. On the other hand, the metabolism and working process of angiotensin II in vitro and in vivo may be different. In in vitro experiments in our system, angiotensin II was administered only once for 24 h and may have been degraded during 24-h culture, while in vivo, although the concentration of the angiotensin II is much lower, it is synthesized/delivered and works continuously on Ca V 1.2 expression for a much longer time. Consequently, the final effect may be similar to the in vitro results shown here. Although NAD(P)H oxidase inhibitors DPI and apocynin exert some nonspecific effects [53] [54] [55] , it is still very likely that the inhibition of H 2 O 2 generation in response to angiotensin II by these inhibitors is involved in the reduced angiotensin II-induced Ca V 1.2 upregulation. First, apocynin has been reported to inhibit O 2 -generation in vascular endothelial cells [8] and vascular O 2 -generation from endothelial cells in the arterial wall [12] . Second, DPI and apocynin, two chemically unrelated NAD(P)H fig. 5 ) . Third, H 2 O 2 , which can be generated from superoxide produced by endothelial NAD(P)H oxidase, upregulated Ca V 1.2 expression in both endothelium-intact arteries ( fig. 3 ) and arteries with damaged endothelium ( fig. 6 ) . Finally, the effects of DPI and apocynin were further confirmed by the inhibitory actions of a more specific NAD(P)H oxidase inhibitor, gp91ds-tat [16, 17, 28, 29] , on both Ca V 1.2 expression and H 2 O 2 production.
These results may relate to changes in blood pressure in vivo. Interruption of the NAD(P)H oxidase signaling pathway has been shown to reduce blood pressure [17, 33, 56] . Selective knock out [56] or inhibition of gp91 phox [17] , a phagocytic NAD(P)H oxidase subunit which is only expressed in endothelium but not in vascular smooth muscle cells [51] , decreased both basal blood pressure [56] and angiotensin II-induced blood pressure elevation [17] . The NAD(P)H oxidase inhibitor apocynin has also been shown to reduce blood pressure in angiotensin II-infused animals [33] . In principle, the acute vasoconstrictive effects of angiotensin II could contribute to its elevation of blood pressure. However, angiotensin II effects on isolated vessels tend to desensitize [57, 58] , whereas its effects on blood pressure in vivo tend to be maintained as long as the exposure continues [4] . An increase in Ca V 1.2 protein may help compensate for any desensitization of the tissue toward the acute pressor action of angiotensin II. An increase in L-type Ca channel activity has been associated with angiotensin II infusion in rats [4] . Therefore, an increase in L-type Ca 2+ channel expression (and activity) might contribute to blood pressure increases associated with elevated angiotensin II levels under pathophysiological conditions.
Although the involvement of isoform specificity of NADPH oxidase was not studied directly in this study, we assume that it is very likely that the phagocytic isoform of gp91 phox (also known as nox2) was involved in the upregulation of Ca V 1.2 expression. First, our studies showed that this action of angiotensin II required an intact endothelium, and gp91 phox is only expressed in endothelium [51] . Second, gp91ds-tat is an NAD(P)H oxidase inhibitor which mainly inhibits the gp91 phox isoform. H 2 O 2 is also known to stimulate the nonphagocytic NAD(P)H oxidase in vascular smooth muscle cells [37] and to stimulate multiple signaling pathways in vascular smooth muscle [59] . Our results clearly indicate that inhibitors of NAD(P)H oxidase act on the endothelial enzyme complex to reduce H 2 O 2 generation ( fig. 5 ), but they also block the downstream effect of H 2 O 2 in the vascular smooth muscle ( fig. 6 ) .
We endorse the notion that H 2 O 2 should be added to the list of endothelially derived substances which affect vascular smooth muscle as a paracrine mediator [60] under pathophysiological conditions at least. Our results suggest that angiotensin II-stimulated H 2 O 2 generation by endothelium contributes to the upregulation of Ca V 1.2 channels in vascular smooth muscle in cultured arteries.
